Showing promise in the landscape of weight management management, retatrutide presents a unique approach. Different from many available medications, retatrutide functions as a twin agonist, simultaneously affecting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) receptors. This simultaneous activation promote